{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:57:04Z","timestamp":1780624624328,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.eplepsyres.2020.106428","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:12:39Z","timestamp":1594786359000},"page":"106428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Impact of enzyme-inducing anti-epilepsy drugs on lipid levels in elderly patients with epilepsy"],"prefix":"10.1016","volume":"166","author":[{"given":"Satoshi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2020.106428_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jama.1990.03440030080025","article-title":"Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?","volume":"263","author":"Benfante","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1528-1157.2003.44802.x","article-title":"Lipoprotein(a) concentration increases during treatment with carbamazepine","volume":"44","author":"Br\u00e4mswig","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1991.tb04691.x","article-title":"Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital","volume":"83","author":"Calandre","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1528-1157.1992.tb02299.x","article-title":"The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients","volume":"33","author":"Calandre","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/jamainternmed.2017.1457","article-title":"Risks of statin therapy in older adults","volume":"177","author":"Curfman","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.290.7.891","article-title":"Major risk factors as antecedents of fatal and nonfatal coronary heart disease events","volume":"290","author":"Greenland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1532-5415.1988.tb04370.x","article-title":"Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study","volume":"36","author":"Harris","year":"1988","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archneur.1993.00540060030012","article-title":"Serum lipid levels during carbamazepine medication. A prospective study","volume":"50","author":"Isoj\u00e4rvi","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0050","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","article-title":"Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine","volume":"35","author":"Isojarvi","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0055","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1111\/j.1532-5415.2010.02915.x","article-title":"Influence of age and health behaviors on stroke risk: lessons from longitudinal studies","volume":"58","author":"Kelly-Hayes","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0060","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0065","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/epi.12338","article-title":"Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy","volume":"54","author":"Kim","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","volume":"12","author":"LoPinto-Khoury","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0075","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2014\/8744.4682","article-title":"Evaluation of effect of antiepileptic drugs on serum lipid profile among young adults with epilepsy in a tertiary care hospital in Pondicherry","author":"Manimekala","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2013.6184","article-title":"Statins and musculoskeletal conditions, arthropathies, and injuries","volume":"173","author":"Mansi","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1684\/ecn.2011.0284","article-title":"New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid","volume":"22","author":"Meral","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of isch\u00e6mic heart-disease","volume":"305","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yebeh.2016.02.023","article-title":"Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein","volume":"58","author":"Mintzer","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0105","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/epi.14554","article-title":"Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly","volume":"59","author":"Mintzer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.eplepsyres.2018.02.001","article-title":"Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: impact of concomitant statins and enzyme-inducing antiepileptic drugs","volume":"141","author":"Mintzer","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.001974","article-title":"Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan","volume":"1","author":"Nagasawa","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0120","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O\u2019Donnell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.4.5988.85","article-title":"Increase in serum cholesterol during phenytoin treatment","volume":"4","author":"Pelkonen","year":"1975","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0135","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1468-1331.2012.03708.x","article-title":"Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population","volume":"19","author":"Phabphal","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0140","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Prospective Studies Collaboration","year":"2007","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","article-title":"Fasting serum insulin and lipid levels in men with epilepsy","volume":"60","author":"Pylv\u00e4nen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0150","doi-asserted-by":"crossref","first-page":"e103856","DOI":"10.1371\/journal.pone.0103856","article-title":"Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia","volume":"9","author":"Rakitin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.seizure.2017.03.007","article-title":"Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: a prospective study","volume":"48","author":"Sidhu","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1528-1157.1999.tb00744.x","article-title":"Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study","volume":"40","author":"Sudhop","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.seizure.2013.06.005","article-title":"Clinical characteristics and treatment responses in new-onset epilepsy in the elderly","volume":"22","author":"Tanaka","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/epi4.12295","article-title":"Prevalence of adult epilepsy in a general Japanese population: the Hisayama study","volume":"4","author":"Tanaka","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ageing\/afq180","article-title":"Longitudinal changes in serum lipids in older people the Turku elderly study 1991-2006","volume":"40","author":"Upmeier","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.08.027","article-title":"Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients","volume":"127","author":"Yamamoto","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0185","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2020.106428_bib0190","doi-asserted-by":"crossref","DOI":"10.1007\/BF00208485","article-title":"Changes of serum lipid patterns during long-term anticonvulsive treatment","volume":"71","author":"Zeitlhofer","year":"1993","journal-title":"Clin. Investig."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121120301868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121120301868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:45:36Z","timestamp":1760276736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121120301868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":38,"alternative-id":["S0920121120301868"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106428","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of enzyme-inducing anti-epilepsy drugs on lipid levels in elderly patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106428"}}